Advancing Integrative Medical Care

Sunil Aggarwal, MD, PhD, FAAPMR is a Board-Certified Physician in Hospice and Palliative Medicine and Physical Medicine and Rehabilitation and Medical Geographer and serves as the Past Chair of the American Academy of Hospice and Palliative Medicine (AAHPM) Integrative Medicine Special Interest Group and an inaugural member of the Safe Use in Psychedelic-Assisted Therapies Forum.
He was recently named as a Top 20 Emerging Leader by the AAHPM. He is an Affiliate Assistant Clinical Professor in Rehabilitation Medicine at the University of Washington School of Medicine, an Affiliate Assistant Professor in the Department of Geography, and an Affiliate Clinical Faculty with Bastyr University. He completed his MD and PhD degrees at the University of Washington and Residency and Fellowship at Virginia Mason Medical Center, NYU Langone Health, and the NIH Clinical Center. He is a Co-founder, Co-director and practitioner at the Advanced Integrative Medical Science (AIMS) Institute in Seattle, a multispecialty teaching clinic and research institute offering cutting edge care in oncology, psychiatry, neurology, rehabilitation, pain, and palliative care. He also serves as an Associate Hospice Medicine Director and On-Call Palliative Physician for a Puget Sound based healthcare system. He has published over three dozen peer-reviewed article and book chapters that have been cited over 800 times per Google Scholar.

8:32 Dr. Aggarwal describes the unique cancer care at the Advanced Integrative Medical Science (AIMS) Institute in Seattle.
13:50 Dr. Diva’s take on how this approach is revolutionary compared to the standard of cancer care.
18:48 How AIMS Institute’s approach translates to treating chronic conditions beyond cancer.
21:24 Dr. Aggarwal’s approaches to psycho-spiritual healing.
27:05 Dr. Aggarwal explains his utilization of ketamine-assisted therapies, and his legal efforts to expand patients’ access to other psychedelics including psilocybin.
32:58 Dr. Aggarwal’s perspective on how psychedelic therapies assist in overall healing and wellbeing.
36:59 The power of psychedelics as psychoplastogens—and the psychology of awe.
41:10 Discussing dosages for ketamine-assisted therapy.
44:13 The ongoing efforts to track how AIMS’ integrative approach compares to the current standards of care.
48:17 Contact info, and how to utilize the services of the AIMS Institute.

Links mentioned in this episode:
https://www.aimsinstitute.net/ (AIMS Institute Website)
https://www.facebook.com/aimsinstitutepllc/posts_to_page/ (Facebook)
https://www.instagram.com/aimsinstituteseattle/ (Instagram)
This episode is sponsored by http://www.getchews.com/ (TotumVos Collagen Chews).
You can find TotumVos at www.getchews.com.

*Use code DRDIVA for an additional 10% off your first order.

Latest Blog Posts

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care 

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care 

Healthcare Disparities in African American Communities African Americans continue to face significant disparities in healthcare. From higher mortality rates for chronic conditions like cancer and heart disease to underdiagnosis of autoimmune disorders, these inequities stem from systemic racism, implicit bias, and a lack of cultural sensitivity among providers. Studies show that Black patients are less likely to receive adequate pain management and more likely to feel unheard or dismissed during medical visits. These disparities erode trust in the healthcare system and lead to poorer outcomes and avoidable suffering. For many, navigating the system can feel isolating and disempowering, leaving them ...

Read More
At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

A recent paper in the Frontiers in Medicine states that An underutilized intervention for long  COVID is low dose naltrexone, which has an established safety profile for a variety of conditions. ‘Naltrexone is a non-selective opioid antagonist currently approved by the US Food and Drug Administration (FDA) for the treatment of alcohol and opioid dependence and is prescribed at 50–150 mg daily. At doses below 5 mg, it is considered low-dose naltrexone (LDN), exhibits anti-inflammatory and analgesic properties, and has been used off-label to reduce severity of symptoms in conditions such as fibromyalgia, multiple sclerosis, complex regional pain syndrome, myalgic encephalomyelitis/chronic fatigue ...

Read More
Unusual Suspects

Unusual Suspects

Psychedelic Therapies Gain New Advocates Texas Law Magazine Written by Robin Berghaus. Art by Matthieu Bourel Published November 6, 2024 Marcus Capone served seven combat tours as a Navy SEAL — including missions with SEAL Team Six, the nation’s preeminent counterterrorism unit — before being medically retired in 2013. For years, he struggled to find effective treatments for his traumatic brain injuries, depression, and post-traumatic stress disorder. Capone tried antidepressants, talk therapy, hyperbaric oxygen therapy, transcranial magnetic stimulation, and he visited several brain clinics. Nothing worked. When Capone’s life began falling apart, he considered suicide. His wife was just as ...

Read More
Call Us Text Us
Skip to content